InvestorsHub Logo
icon url

DonDonDonDon

05/24/21 12:51 PM

#167436 RE: Richard_Cranium #167435

Well said Black-0PS, our own FDA changed the time frame so endpoints would fall short, Unbelievable...even more after seeing the interim results.


The FDA had nothing to do with the 42 day endpoint suggestion. The FDA has nothing to do with the interim analysis. The DSMC is who looked at the interim analysis and recommended the 42 day endpoint most likely because they saw there was no benefit at 28 days. The members of the DSMC were chosen by CytoDyn.